All Stories

  1. Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation

    Article • Journal of Oncology, November 2019, Hindawi Publishing Corporation

    MICHELE DE TURSI

  2. A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression

    Article • Case Reports in Oncological Medicine, July 2019, Hindawi Publishing Corporation

    MICHELE DE TURSI

  3. Non Squamous NSCLC patient in clinical practice

    Article • Thoracic Cancer, December 2017, Wiley

    MICHELE DE TURSI, Alessio Cortellini, Corrado Ficorella

  4. Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting

    Article • Journal of Cellular Physiology, September 2017, Wiley

    MICHELE DE TURSI

  5. Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts

    Article • OncoTargets and Therapy, June 2017, Dove Medical Press

    MICHELE DE TURSI, Dr Giuseppe Di Martino

  6. Extraordinary and prolonged Erlotinib-induced clinical response in a patient with EGFR wild-type squamous lung cancer in third-line therapy: a case report

    Article • International Medical Case Reports Journal, May 2017, Dove Medical Press

    MICHELE DE TURSI

  7. Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients' Satisfaction

    Article • Clinical Genitourinary Cancer, April 2017, Elsevier

    MICHELE DE TURSI

  8. P1.06-017 Observational Study on Prolonged Disease Stabilization in Advanced NSCLC EGFR WT/Unknown Patients Treated with Erlotinib in Second Line

    Article • Journal of Thoracic Oncology, January 2017, Elsevier

    MICHELE DE TURSI

  9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

    Article • Cochrane Database of Systematic Reviews, December 2016, Wiley

    MICHELE DE TURSI

  10. Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian “Real-World” SAX Study

    Article • Frontiers in Pharmacology, September 2016, Frontiers

    MICHELE DE TURSI, GAETANO FACCHINI

  11. The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status

    Article • Oncotarget, June 2016, Impact Journals, LLC

    MICHELE DE TURSI, Dr Alessandro Russo

  12. Immunotherapy and Hypophysitis in the Clinical Practice: A Case Report

    Article • Journal of Clinical Case Reports, January 2016, OMICS Publishing Group

    MICHELE DE TURSI

  13. Rivaroxaban for Cancer-associated Cardiac Thrombosis

    Article • The American Journal of Medicine, October 2015, Elsevier

    MICHELE DE TURSI

  14. Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

    Article • Journal of Thoracic Oncology, October 2015, Elsevier

    MICHELE DE TURSI

  15. Breast Cancer “Tailored Follow-up” in Italian Oncology Units: A Web-Based Survey

    Article • PLoS ONE, April 2014, PLOS

    MICHELE DE TURSI

  16. Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer

    Article • Annals of Surgical Oncology, February 2014, Springer Science + Business Media

    MICHELE DE TURSI

  17. Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives

    Article • Expert Review of Anticancer Therapy, June 2013, Taylor & Francis

    Dr Matteo Santoni, Dr Michele Milella, MICHELE DE TURSI, Giovanni Lo Re

  18. Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer

    Article • Journal of Cancer Research and Clinical Oncology, April 2013, Springer Science + Business Media

    MICHELE DE TURSI

  19. Breast cancer follow-up strategies in randomized phase III adjuvant clinical trials: a systematic review

    Article • Journal of Experimental & Clinical Cancer Research, January 2013, Springer Science + Business Media

    MICHELE DE TURSI

  20. Long-term outcome of neoadjuvant systemic therapy for locally advanced breast cancer in routine clinical practice

    Article • Journal of Cancer Research and Clinical Oncology, October 2012, Springer Science + Business Media

    MICHELE DE TURSI

  21. An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors

    Article • Current Cancer Drug Targets, April 2012, Bentham Science Publishers

    MICHELE DE TURSI

  22. Arterial thrombosis in ambulatory cancer patients treated with chemotherapy

    Article • Thrombosis Research, April 2011, Elsevier

    MICHELE DE TURSI

  23. Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer

    Article • Breast Cancer Research and Treatment, September 2008, Springer Science + Business Media

    MICHELE DE TURSI

  24. The 90K Protein Increases Major Histocompatibility Complex Class I Expression and Is Regulated by Hormones, γ-Interferon, and Double-Strand Polynucleotides

    Article • Endocrinology, October 2004, Endocrine Society

    MICHELE DE TURSI